Shengqiang Li

ORCID: 0000-0003-3077-6144 · 1 paper in corpus · active 2021
2021
Integration of Proteomics and Metabonomics in Exploring the Protecting Mechanism of Gushukang Capsule in Osteoporosis Rats
·doi:10.21203/rs.3.rs-1140478/v1

Abstract Background Gushukang (GSK) capsule is a Chinese patent medicine for the treatment of osteoporosis (OP). It has been widely used in clinics. However, the specific mechanism and target of GSK in the treatment of osteoporosis is not…